Work

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Year: 2003

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2003.08.040

Authors: Steven J. Cohen, Linus Ho, Sulabha Ranganathan, James L. Abbruzzese, R. Katherine Alpaugh, Mary Beard, Nancy L. Lewis, Susan McLaughlin, André Rogatko, Juan J. Perez-Ruixo, Amanda M. Thistle, Tom Verhaeghe, Hao Wang, Louis M. Weiner, John J. Wright, Gary R. Hudes, Neal J. Meropol

Institutions: Fox Chase Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2061887576, CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM, PHASE II/III CLINICAL TRIALS OF ANTICANCER AGENTS, G6154459055, Comprehensive Cancer Center Program at Fox Chase, Cancer Center Support Grant

OpenAlex ID: W2125244026

FWCI: 8.526

Cites: 22

Cited by: 174

Related to: 10